Clinical efficacy of leflunomide in primary Sjogren's syndrome is associated with regulation of T-cell activity and upregulation of IL-7 receptor α expression.

A. Bikker; J.M. van Woerkom; A.A. Kruize; K.M. Wurff-Jacobs; J.W.J. Bijlsma; F.P.J.G. Lafeber; J.A.G. van Roon

doi:10.1136/annrheumdis-2011-201026.

Clinical efficacy of leflunomide in primary Sjogren's syndrome is associated with regulation of T-cell activity and upregulation of IL-7 receptor α expression.

Translated title of the contribution: Clinical efficacy of leflunomide in primary Sjogren's syndrome is associated with regulation of T-cell activity and upregulation of IL-7 receptor α expression.

A. Bikker
, J.M. van Woerkom
, A.A. Kruize
, K.M. Wurff-Jacobs
, J.W.J. Bijlsma
, F.P.J.G. Lafeber
, J.A.G. van Roon

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Clinical efficacy of leflunomide in primary Sjogren's syndrome is associated with regulation of T-cell activity and upregulation of IL-7 receptor α expression.
Original language	Undefined/Unknown
Pages (from-to)	1934-1941
Number of pages	8
Journal	Annals of the Rheumatic Diseases
Volume	71
Issue number	12
DOIs	https://doi.org/10.1136/annrheumdis-2011-201026.
Publication status	Published - 2012

Access to Document

10.1136/annrheumdis-2011-201026.

Cite this

Bikker, A., van Woerkom, J. M., Kruize, A. A., Wurff-Jacobs, K. M., Bijlsma, J. W. J., Lafeber, F. P. J. G., & van Roon, J. A. G. (2012). Clinical efficacy of leflunomide in primary Sjogren's syndrome is associated with regulation of T-cell activity and upregulation of IL-7 receptor α expression. Annals of the Rheumatic Diseases, 71(12), 1934-1941. https://doi.org/10.1136/annrheumdis-2011-201026.

@article{17a86d75600a4ab98ade4cb672be66b4,

title = "Clinical efficacy of leflunomide in primary Sjogren's syndrome is associated with regulation of T-cell activity and upregulation of IL-7 receptor α expression.",

author = "A. Bikker and \{van Woerkom\}, J.M. and A.A. Kruize and K.M. Wurff-Jacobs and J.W.J. Bijlsma and F.P.J.G. Lafeber and \{van Roon\}, J.A.G.",

year = "2012",

doi = "10.1136/annrheumdis-2011-201026.",

language = "Undefined/Unknown",

volume = "71",

pages = "1934--1941",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "Elsevier",

number = "12",

}

Bikker, A, van Woerkom, JM, Kruize, AA, Wurff-Jacobs, KM, Bijlsma, JWJ, Lafeber, FPJG & van Roon, JAG 2012, 'Clinical efficacy of leflunomide in primary Sjogren's syndrome is associated with regulation of T-cell activity and upregulation of IL-7 receptor α expression.', Annals of the Rheumatic Diseases, vol. 71, no. 12, pp. 1934-1941. https://doi.org/10.1136/annrheumdis-2011-201026.

TY - JOUR

T1 - Clinical efficacy of leflunomide in primary Sjogren's syndrome is associated with regulation of T-cell activity and upregulation of IL-7 receptor α expression.

AU - Bikker, A.

AU - van Woerkom, J.M.

AU - Kruize, A.A.

AU - Wurff-Jacobs, K.M.

AU - Bijlsma, J.W.J.

AU - Lafeber, F.P.J.G.

AU - van Roon, J.A.G.

PY - 2012

Y1 - 2012

U2 - 10.1136/annrheumdis-2011-201026.

DO - 10.1136/annrheumdis-2011-201026.

M3 - Article

SN - 0003-4967

VL - 71

SP - 1934

EP - 1941

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - 12

ER -